Recently developped radioimmunoassays (RIA) for the analysis of anabolic steroids and their metabolites in biological fluids were tested for cross-reactivity with other types of steroids. Results show that the degree of desirable cross-reactivity within the two classes of orally active anabolic steroids vary widely and that the antiserum for 19-Nortestosterone (the active principle of intramuscular, preparations) has a very high degree of undesirable crossreactivity with components of oral contraceptives. Single and multiple dose studies in human volunteers demonstrate that the detection level and degree of retrospectivity are likewise variable but that the test easily detects most anabolic steroids during treatment. At the present time, the combination of the three antisera for the assay of a sample appears to be a relatively rapid and economic method for screening large numbers of samples in situations where doping control of anabolic steroids is required. The importance of utilizing physico-chemical means for identification of RIA potential positives is emphasized.
INTRODUCTION
Anabolic steroids are chemical and functional relatives of the male sex hormones or androgenic hormones. One of their most remarkable effects is to promote a rapid increase in height and development of the skeletal musculature which, with thickening of the skeleton, contributes to a rapid increase in body weight. This is called the anabolic effect. Several related steroids have been synthesized in an attempt to separate the anabolic properties from the androgenic activity of testosterone so as to obtain compounds which might promote body growth without having masculinizing effects. A complete dissociation of these two effects has, however, yet to be achieved. In spite of all the dangers associated with their use, these compounds have found a wide and uncontrolled application in sports.
It appears that the major doping problem at the present time is the abuse of anabolic steroids. Until 1974, no method was available that was sensitive enough for the routine detection of anabolic steroids and their metabolites in biological fluids, thus preventing their inclusion in lists of drugs banned by the major international sports organizations and their control at international competitions. Certain anabolic steroids became detectable with the introduction of a radioimmunoassay
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Canada. (Sumner, 1974 : Brooks et al, 1975 and identification procedures for a limited number of them have also been described (Ward et al: 1975) .
Following these and other developments, the Inter--national Olympic Committee banned the use of anabolic steroids in sports competitions and the major international sports The method described by Brooks et al (1975) was used with minor modifications and is summarized here for convenience. 0.5 ml of unbuffered urine is extracted once with 2.5 ml of freshly redistilled methylene chloride. The organic layer is washed once with NaOH 0.1N and three times with distilled water. The washed organic extract is taken to dryness in a Vortex Evaporator (Buchler) and acetylated overnight with acetic anhydride in pyridine. After acetylation, 2 ml of methanol are added to the tube, and the solvent and excess reagents are dried down. The extract is finally taken up in 2.5 ml of assay buffer. Each determination is the average of triplicate 0.1 ml aliquots.
The radioimmunoassay for the 17-a-ethyl and 17-a-methyl anabolic steroids have similarly been described by Brooks et al (1975) . The method involves the following successive steps: coating of antibodies onto plastic tubes, pre-incubation of sample or standards in assay buffer, incubation with the label solution and counting the tubes in a gamma ray spectrometer.
For the assays, the 1 7-a-methyltestosterone (for 17-a-methyl anabolic steroids) and Norethandrolone (for 17-a-ethyl anabolic steroids) antisera were diluted according to titre requirements (1:25,000 and 1:20,000 respectively Table 11 reveals that the 17-a-methyl anabolic steroids cross-react to very different degrees. As shown, the cross-reactivity of 17-oaethyl derivatives, 19-Nortestosterone and some widely used anti-inflammatory steroids is, for all intents and purposes, negligible. But there is a significant and undesirable degree of cross-reactivity with Norethindrone and Norgestrel which are present in many oral contraceptive preparations. It is further noted that the undesirable cross-reactivity of these two compounds is higher than the desirable but very low reactivity of three 17-a-methyl anabolic steroids. Table III shows that Ethylestrenol, a 17-a-ethyl anabolic steroid, cross-reacts to the extent of only 28% with the Norethandrolone antiserum. Norethindrone has an undesirable reactivity of 6.6%. Table IV shows that the 1 9-Nortestosterone antiserum cross-reacts with Norethandrolone but does not with Ethylestrenol (<1%). This is rather unexpected since Norethandrolone differs from Ethylestrenol by a single structural feature, a keto group in the 3-position, and the specificity of the antiserum is directed at the absence of the methyl group in the 19-position, a feature which both compounds share. It is also important to note that Norgestrel and Norethindrone cross-react very significantly, indicating that false positives may possibly be obtained from female athletes using oral contraceptives. This antiserum therefore lacks specificity and cannot be used in lieu of the 17-a-ethyl antiserum for screening purposes because its reactivity to Ethylestrenol is negligible. fig. 2) , Norethandrolone ( fig. 3 ) and 19-Nortestosterone (Fig. 4) tinguishable from blank urine values. The blank values were chosen as 2 ng/ml for Methanedienone, 0.5 ng/ml for Norethandrolone and 2.5 ng/ml for 19-Nortestosterone as determined in a large number of drug-free urine samples obtained from normal volunteers.
The results of multiple-dose studies are shown in Table VI . These indicate that most anabolic steroids, with the notable exception of Stanozolol, may be easily and quantitatively detected during treatment. The degree of retrospectivity is however extremely variable after administration of normal doses. Given the very high dosages that athletes are said to use, it is probable that these compounds may be detected for a much longer time after treatment interruption. The degree of retrospectivity could, in addition, be increased by extraction of larger volumes or by hydrolyzing samples before extraction. Results from this laboratory (Bertrand, M., Masse, R. and Dugal, R. to be published) using chemical ionization gas chromatography/mass spectrometry have also shown that a more effective detection of most anabolic steroids may be made with this technique. The principal disadvantage however of using GC/MS for handling a large number of samples is the length of time required for each analysis and the relatively high cost of using sophisticated equipment. Thus, the three radioimmunoassays used in parallel constitute, at the present time, a relatively rapid and economical method for the detection of most anabolic steroids. But caution should be exercized in interpreting results because the method has some very serious limitations and should therefore be considered strictly as a preliminary screening technique.
As an illustration of results obtained with actual samples from athletes, Table VII shows the RIA values (with the three antisera) for those samples which were subsequently identified by gas-chromatography/mass spectrometry at the Montreal Olympic Games. Assuming that these athletes were taking only one anabolic steroid (and no evidence to the contrary could be found), it appears that the cross-reactivity between antisera becomes important when concentrations resulting from large doses of anabolic steroids are found in urine. This may however be considered as an advantage since positive results with two or three antisera may serve as strong preliminary evidence of the presence of an anabolic steroid in the sample. It has however the disadvantage of not being a very useful indication as to the exact class of compound present in the sample.
The length of time required for the assay of 17-amethyl anabolic steroids is, at the present time, about 2 or 3 days depending on working schedules. This represents some disadvantage in situations where results have to be delivered rapidly, as in international competitions. It was found that the elimination of the acetylation step in the sample preparation procedure could contribute considerably to shorten the time of analysis. Negative urine samples obtained from athletes during the Montreal Olympic Games were analyzed simultaneously by the conventional method and by eliminating the acetylation step. Non-acetylated aliquots gave slightly higher response readings than acetylated samples but the responses were always lower than the chosen limit of detection. Moreover, values of non-acetylated samples were not significantly different (p = 0.1) from those obtained from acetylated samples (as determined by the paired values t-test). Bypassing the acetylation step may introduce some risk of increasing the number of false positives but reduces the analysis time by about 50%. The authors estimate that this risk is acceptable in situations where a large number of samples have to be analyzed in international competitions and where the time constraints imposed on the laboratory are important. It is evidently necessary that gas chromatography/mass spectrometry facilities be available to confirm all R IA results. All values are in weight equivalents of marker (ng/ml of urine)
